Skip to content

Earlier editions: 2020-112018-112026-09

DIVISION 107. HEALTH CARE ACCESS AND INFORMATION 127000-130079›PART 2. HEALTH POLICY AND PLANNING 127280-127774›CHAPTER 10. California Affordable Drug Manufacturing Act of 2020 127690-127697

§ 127691

California Health and Safety Code · 2026-10 edition · updated 2026-10-04 · California

For purposes of this chapter, the following definitions apply:

(a) “Generic drug” means a drug that is approved pursuant to subdivision (j) of Section 355 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 301 et seq.), or a biosimilar, as defined under the federal Public Health Service Act (42 U.S.C. Sec. 262).

(b) “Partnerships” include, but are not limited to, agreements for the procurement of generic prescription drugs by way of contracts, grant agreements, or purchasing by a payer, state governmental agency, group purchasing organization, nonprofit organization, or other entity.

(c) “California Health and Human Services Agency” or “CHHSA” means the California Health and Human Services Agency, or any of its departments, including the Department of Health Care Access and Information, selected to implement this chapter.

(Amended by Stats. 2023, Ch. 42, Sec. 50. (AB 118) Effective July 10, 2023.)

Get a plain-English answer with a citation back to this text.

Ask AI about this code
▸Contents — California Health and Safety Code

GoCodebook provides public access, search, citation, multilingual explanation, and practical interpretation of legally adopted building regulations. It is not a substitute for the official ICC or California code publications.